MOUNJARO 2.5MG/0.6ML KWIK PEN INJ. 4DOSE

Mounjaro is a once-weekly, subcutaneous injection that contains tirzepatide, a dual GIP/GLP-1 receptor agonist. The 2.5 mg strength is commonly used as a starting dose to help your body get used to treatment before any dose increases your doctor may prescribe. The pre-filled, single-use pen is designed for at-home administration with a simple, discreet injection experience when used exactly as prescribed.Benefits:- Helps support weight reduction when combined with diet and exercise.- Helps improve blood-sugar control in adults with type 2 diabetes, when used along with a balanced diet and regular physical activity.- The once-weekly schedule can support adherence, because you inject on the same day each week.Main Ingredient & Its Benefits:- Tirzepatide: A dual agonist of the GIP and GLP-1 receptors. By acting on both pathways, tirzepatide helps the body enhance glucose-dependent insulin secretion, decrease glucagon levels, and slow gastric emptying, which together contribute to better post-meal and overall glycaemic control.Note:- Does not contain pins for injection.